Abbott's Higher Than Expected Q2 Earnings: Analyst Foresees Strong Performance In 2024
Portfolio Pulse from Vandana Singh
Abbott Laboratories reported better-than-expected Q2 earnings with an organic sales growth of 11.5%. The company reaffirmed its FY23 adjusted EPS of $4.30 - $4.50. Analysts from William Blair and Citi have a positive outlook for the company, expecting strong performance in 2024. ABT shares are up 2.10% at $114.18.
July 21, 2023 | 5:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Abbott Laboratories reported strong Q2 earnings and analysts predict a strong performance in 2024. The company's stock is up 2.10%.
Abbott Laboratories reported better-than-expected Q2 earnings, which is a positive signal for investors. Analysts from William Blair and Citi have a positive outlook for the company, expecting strong performance in 2024. This positive sentiment from analysts and strong earnings report are likely to have a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100